Product Image

Double Strength Ginkgo Biloba 120 mg

NOW
4.8
★ ★ ★ ★ ★
(38311 ratings)
Ginkgo
Eleuthero 250 mg
Product Image
Score79
A practical ginkgo formula in a smaller bottle, with weak eleuthero dosing and incomplete extract-quality details.
How scoring works
Quantity:50 Capsule(s) • (50 servings)
Goals:
Brain Health
Cognitive Support
Mental Focus

Score 79

A practical ginkgo formula in a smaller bottle, with weak eleuthero dosing and incomplete extract-quality details.
How scoring works

Also available as

2 options
100 servings Eleuthero 250 mg, Ginkgo 120 mg • 100 Capsule(s) • 100 servings $10.76 ($0.10 per serving) 200 servings Eleuthero 250 mg, Ginkgo 120 mg • 200 Capsule(s) • 200 servings $21.84 ($0.10 per serving)
$6.97($0.13 per serving)
iHerb
$ 7.33
Pure Formulas
$ 7.13
iHerb
$ 7.33
Vitacost
$ 6.97
Daily Vita
$ 7.00
Amazon
$ 7.00
Report prices

Analysis

Ginkgo is the meaningful active, with a daily amount that fits common cognitive-support use. Eleuthero adds a related stress-resilience idea but is unlikely to carry the formula at its listed amount.

Flavonglycosides and terpene lactones are named without percentages, and no ginkgolic-acid specification is given. Eleuthero also lacks its plant part, extract type, and marker standardization.

The 50-serving bottle is useful for trying the routine without committing to a bulk supply. It is better aligned with cognition and mental stamina than broad vision support, and medication interactions require attention.

Who is it for
  • Adults trying ginkgo-based cognitive support
  • People who prefer a smaller bottle before buying in bulk
Best for
  • Short-term trial of a ginkgo routine
  • Non-stimulant cognitive support

Pros

  • Provides 120 mg of ginkgo extract
  • Names the major ginkgo marker groups
  • Includes 250 mg of organic eleuthero
  • Offers practical entry-level package value

Cons

  • Ginkgo marker percentages are absent
  • No ginkgolic-acid limit is given
  • Eleuthero is low and unstandardized
  • Broad vision support is lacking

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.
  • Eleuthero may affect blood pressure or stimulant sensitivity in susceptible users.

Nutrient quality

78 High impact

The ginkgo amount is practical and the marker groups are identified. Missing marker percentages, purity limits, and eleuthero standardization reduce confidence in quality.

.

Ingredient transparency

76 High impact

Both botanical amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.

.

Customer satisfaction

73 High impact

The supplied average rating is strong and comes from a very large rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

92 Highest impact

A practical ginkgo amount and low serving cost create strong value. Missing marker percentages are the main quality limitation.

.
Report analysis

Goals

Brain Health
Brain Health
Impact
Highest effect
A- Goal FitB+ Strength of SupportB- CoverageA Formula Quality

Ginkgo extract directly supports cerebral circulation, while eleuthero may help cognitive stamina under stress. The ginkgo amount fits a commonly used daily range.

Missing marker percentages weaken potency assurance, and the eleuthero is not standardized. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Cognitive Support
Cognitive Support
Impact
High effect
A Goal FitC+ Strength of SupportC+ CoverageB Formula Quality

The full ginkgo extract amount directly supports cerebral circulation and is well aligned with memory and attention. Eleuthero adds a stress-resilience angle, creating broader cognitive intent than ginkgo alone.

Ginkgo marker percentages are missing, and the eleuthero amount falls below the usual raw-powder threshold with no standardization details. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Study evidence
Eleuthero No effect 1 study
Ginkgo Supportive 87 studies
Mental Focus
Mental Focus
Impact
High effect
C+ Goal FitB- Strength of SupportC- CoverageB- Formula Quality

Ginkgo may support attention through cerebral circulation, while eleuthero may add mild stress-resilience support. Evidence is mixed for ginkgo in healthy adults, and the eleuthero amount is low.

The ginkgo extract amount fits a common daily range, but marker percentages and purity limits are missing. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero Disputed 3 studies
Ginkgo Supportive 28 studies
Productivity Boost
Productivity Boost
Impact
Moderate effect
B- Goal FitC Strength of SupportC- CoverageB- Formula Quality
Eleuthero · 250 mgEleuthero · 250 mg

Ginkgo and eleuthero combine circulation support with possible stress-fatigue support, giving the formula reasonable productivity relevance. Ginkgo has mixed human evidence and eleuthero evidence is less certain at the low supplied amount.

The 120 mg ginkgo extract is plausible, while 250 mg of unstandardized eleuthero falls short of a strong standalone amount. The pairing is conceptually complementary, but ginkgo may raise bleeding risk with anticoagulants, antiplatelet medicines, or around surgery.

Study evidence
Eleuthero No effect 1 study
Eleuthero Not classified

No linked studies yet.

Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Vision Support
Vision Support
Impact
Moderate effect
D- Goal FitC+ Strength of SupportD- CoverageC- Formula Quality

A full ginkgo extract amount may support ocular microcirculation in specific situations, but it is not a core broad-spectrum vision formula. Evidence for ocular outcomes is less established than for macular carotenoids or AREDS2 nutrients.

The label names key ginkgo marker groups without stating their percentages or a ginkgolic-acid purity limit, while eleuthero adds little direct vision relevance. Ginkgo may increase bleeding risk when used with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
 120 mg
organic Eleuthero
250 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Women Vegetarian
Report overview
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore77
D- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The extract amount fits the commonly used daily range, and both key marker groups are named. Missing marker percentages and ginkgolic-acid testing leave quality less certain. The cost per reference dose is very favorable. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

View ingredientView products
Eleuthero · 250 mg OverallScore27
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The capsule clearly states the eleuthero amount but omits its plant part, extract type, and active-marker standardization. The low amount does not meet the minimum powder threshold, so the inexpensive serving does not translate into effective eleuthero value. Ginkgo may increase bleeding risk when combined with warfarin, antiplatelet medicines, or before surgery.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A well-standardized branded extract supplies a meaningful ginkgo amount with stronger purity assurance. It omits eleuthero, and ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A recognized phytosome form provides enhanced-delivery support at a well-matched amount. The focused formula lacks eleuthero and still carries the usual ginkgo bleeding-interaction caution.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
The full extract amount and named flavone-glycoside and terpene-lactone groups improve focused ginkgo coverage. Marker percentages and a purity limit remain missing, while eleuthero is not included.
83 Budget

Ginkgo Biloba 60 mg

NOW
A very long supply provides a maintenance ginkgo extract plus leaf powder at a much lower recurring cost. Marker groups are named without percentages, and the formula omits eleuthero.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A full 120 mg extract with named marker groups and a low ginkgolic-acid limit costs less per serving. It provides stronger purity assurance but does not preserve the original eleuthero.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A recognized GinkgoSelect extract offers maintenance-level ginkgo support at a lower serving cost. Eleuthero is absent, and ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
84 Value

Ginkgo Biloba 120 mg

Nature's Bounty
A full daily ginkgo amount and long supply provide strong practical value at a low recurring cost. Marker percentages and purity limits are absent, and the product drops the original eleuthero.
81 Value

Extra Strength Ginkgo 120 mg

Doctor's Best
A full target-range extract amount is paired with favorable serving economics and extensive customer feedback. Marker percentages and a purity limit are not fully disclosed, and no eleuthero is provided.
83 Value

Eleuthero Root 425 mg

Swanson Premium Brand
A focused whole-herb eleuthero serving and low recurring cost preserve the original adaptogen component. It omits ginkgo, while species, root identification, and eleutheroside standardization are not confirmed.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  2. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  3. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  4. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  5. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  6. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  7. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  8. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
    Schaffler K; Wolf OT; Burkart M · Pharmacopsychiatry · 2014
    Randomized trial144 participantsCognitive Support Mental Focus Productivity Boost forEleuthero
  9. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  10. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  11. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  12. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
    Panossian A; Wikman G · Current clinical pharmacology · 2009
    Narrative reviewMental Focus forEleuthero
  13. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
    Panossian A; Wagner H · Phytotherapy research : PTR · 2005
    Narrative reviewMental Focus forEleuthero
  14. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  15. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  17. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  18. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  19. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  20. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  21. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  22. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  23. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  24. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  25. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  26. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  27. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  28. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo